Weil Company’s Oracle ORCL Stock Holding History

Weil Company’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,063	Closed	-$299K	–	119
2025 Q3	$299K	Buy	1,063 +123	+13%	+$31.3K	0.07%	101
2025 Q2	$205K	Buy	+940	New	+$152K	0.05%	113
2019 Q4	–	Sell	-325	Closed	-$18K	–	260
2019 Q3	$18K	Buy	+325	New	+$18K	0.01%	250

Other funds holding ORCL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weil Company's ORCL Position: Q4 2025 in Review

Weil Company sold out of Oracle (ORCL) in Q4 2025, closing a stake of 1,063 shares — an estimated $299K sold.

Weil Company first reported a position in ORCL in Q3 2019 and held it in 3 quarters. The position peaked at $299K in Q3 2025. 3,759 funds tracked by Wall St. Rank hold ORCL as of Q4 2025.

Weil Company reported no remaining Oracle position as of Q4 2025 after selling out during the quarter.
Weil Company sold 1,063 Oracle shares in Q4 2025, an estimated $299K.
Weil Company first reported a position in Oracle in Q3 2019 and held it in 3 quarters.
Weil Company's Oracle position peaked at $299K in Q3 2025.
3,759 funds tracked by Wall St. Rank held Oracle as of Q4 2025.

Based on Weil Company's 13F filing for Q4 2025, filed 14 Jan 2026.